Delivery Order SPE2DB22D3004-SPE2DB25FRS71
Award Date 7/31/25
Potential Completion Date 8/21/25
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $7,203.40 to AmerisourceBergen Drug Corp for XOLAIR 150 MG/1.2 ML Powder vials under a firm fixed-price contract. The award was made on July 21, 2025, with an ultimate completion date of August 11, 2025. This is a non-set-aside, competitively awarded delivery order that will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. XOLAIR (omalizumab) is a monoclonal antibody therapy commonly used for treating...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Xolair 75 mg/0.5 ml syringes with a ceiling value of $1,080.54 and a firm fixed price structure. This delivery order is non-set-aside and represents a competitively awarded contract with an ultimate completion date of August 11, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- This delivery order, awarded July 30, 2025, to AmerisourceBergen Drug Corp provides XOLAIR 150 mg/1.2 mL powder vials valued at $5,005.50 with a firm fixed price structure. The contract is non-set-aside and competitively awarded, with an ultimate completion date of August 20, 2025. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics...
- This delivery order, valued at $8,644.08, was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Xolair 150 mg/1.2 mL powder vials. The contract is firm fixed price with no set-aside designation, indicating competitive award. Performance will be completed by August 18, 2025, and will take place at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of XOLAIR 300 mg/2 mL auto-injector vials with a ceiling value of $1,594.16 and firm fixed pricing. This is a non-set-aside competitive award with an ultimate completion date of August 22, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order for XOLAIR 150 mg/ml syringes valued at $108,051.00 under a firm fixed-price contract. This non-set-aside award was issued on July 31, 2025, with an ultimate completion date of August 21, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. XOLAIR is a biologic medication used to treat moderate-to-severe allergic asthma and other...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,800.90 to AmerisourceBergen Drug Corp for the supply of XOLAIR 75 mg/0.5 ml syringes. This competitively awarded, firm fixed-price delivery order was established on August 1, 2025, with an ultimate completion date of August 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of XOLAIR 150 mg/ml syringes, with a contract ceiling value of $5,762.72 and an ultimate completion date of August 19, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation, performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $41,712.50 to AmerisourceBergen Drug Corp for XOLAIR 150 MG/1.2 ML Powder Vials. This competitively awarded, firm fixed-price contract does not utilize a set-aside designation and carries an ultimate completion date of August 19, 2025. AmerisourceBergen Drug Corp will perform this delivery order from its corporate headquarters location in Conshohocken, Pennsylvania, leveraging its extensive capabilities as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of XOLAIR 300 mg/2 ml auto-injector prefilled syringes. This competitive award, valued at $3,188.32 with firm fixed pricing, is scheduled for completion by August 18, 2025. The contract represents a direct delivery order under AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical. As a pharmaceutical distributor headquartered in...